WHO ICTRP trial
A randomized, double-blind placebo-controlled clinical trial of Morphine…
ChiCTR-IOR-16009101 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-IOR-16009101 |
|---|---|
| Public title | A randomized, double-blind placebo-controlled clinical trial of Morphine Hydrochloride Injection assisted with Ibuprofen injection for the treatment of postoperative pain. |
| Scientific title | A randomized, double-blind placebo-controlled clinical trial of Morphine Hydrochloride Injection assisted with Ibuprofen injection for the treatment of postoperative pain. |
| Primary sponsor | The Third Affiliated Hospital, Harbin Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | Other |
| Countries | China |
| Conditions | Cervical cancer |
| Interventions | Low-dose group, high-dose group:Different doses |
| Registration date | Aug 26, 2016 |
| Target size | Low-dose group, high-dose group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: